Seattle Genetics Inc. added Alpna Seth to its board.
Seth is the COO of Vir Biotechnology, a San Francisco-based company focused on developing treatments for viral and bacterial diseases.
Prior to joining Vir Biotechnology, she was a senior vice president and the global head of Biogen Inc.'s biosimilars business.
